Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits

MD Glantz; JC Anthony; PA Berglund; L Degenhardt; L Dierker; A Kalaydjian; KR Merikangas; AM Ruscio; J Swendsens; RC Kessler

Journal article

Mental disorders as risk factors for later substance dependence: estimates of optimal prevention and treatment benefits

MD Glantz, JC Anthony, PA Berglund, L Degenhardt, L Dierker, A Kalaydjian, KR Merikangas, AM Ruscio, J Swendsens, RC Kessler

Psychological Medicine | CAMBRIDGE UNIV PRESS | Published : 2009

DOI: 10.1017/S0033291708004510

University of Melbourne Researchers

Louisa Degenhardt Author Melbourne School of Population and Global Health

Grants

Funding Acknowledgements

Professor Kessler has been a consultant for GlaxoSmithKline Inc., Pfizer Inc., Wyeth-Ayerst, SanofiAventis, Kaiser Permanente, and Shire Pharmaceuticals; has served on advisory boards for Eli Lilly & Company and Wyeth-Ayerst; and has had research support for his epidemiological studies from Eli Lilly & Company, Pfizer Inc., Ortho-McNeil Pharmaceuticals Inc., and Bristol-Myers Squibb.